AeroVironment
AVAV
$174.23
+6.83%
AeroVironment, Inc. is a defense technology company specializing in unmanned aircraft systems (UAS), tactical missile systems, and high-altitude pseudo-satellites, primarily serving the U.S. Department of Defense and allied international governments. The company is a recognized leader and technology provider in the unmanned systems and counter-UAS space, delivering integrated capabilities across air, land, sea, space, and cyber domains. The current investor narrative is dominated by a stark dichotomy between the strong secular tailwinds from rising global defense budgets and intense demand for unmanned systems, and the company's recent severe operational setbacks, including a significant Q3 earnings miss, a major goodwill impairment charge, and the termination of a critical $1.7 billion U.S. Space Force contract, which has created substantial uncertainty and driven a steep stock price decline.…
AVAV
AeroVironment
$174.23
Related headlines
AVAV 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AeroVironment's 12-month outlook, with a consensus price target around $226.50 and implied upside of +30.0% versus the current price.
Average Target
$226.50
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$139 - $227
Analyst target range
Analyst coverage for AVAV appears limited in the provided dataset, with only one analyst's estimates shown for revenue and EPS, suggesting insufficient broad consensus data is available to determine a clear average target price or buy/hold/sell distribution. The implications of limited coverage are significant; it often indicates this is a smaller-cap, niche defense name where institutional interest may be waning following recent negative catalysts, leading to higher volatility and less efficient price discovery. The available institutional ratings data from March 2026 shows a series of reiterations from firms like BTIG, Canaccord, and Jefferies maintaining 'Buy' or equivalent ratings, and one upgrade from Raymond James from 'Underperform' to 'Market Perform'. However, the lack of a quantifiable consensus target and upside/downside calculation following the severe March-April price decline makes it difficult to gauge current analyst conviction, and the wide dispersion in potential outcomes is likely reflected in the stock's high volatility and precipitous fall from its highs.
Bulls vs Bears: AVAV Investment Factors
The investment debate for AVAV is a stark battle between powerful secular tailwinds and severe, company-specific operational failures. Currently, the bear case holds stronger evidence, as the catastrophic Q3 earnings miss, contract termination, and cash burn are concrete, present-tense realities, while the bullish narrative relies on future defense spending and a potential operational turnaround. The single most important tension is whether the recent $1.7 billion contract loss and goodwill impairment are one-time, non-recurring events marking a low point, or symptomatic of deeper, systemic execution problems that will prevent the company from capitalizing on the favorable industry backdrop. The resolution of this uncertainty will determine if the stock is a deep-value opportunity or a value trap.
Bullish
- Strong Secular Tailwinds: The company operates in the unmanned systems and counter-UAS sector, which is experiencing intense demand driven by rising global defense budgets and geopolitical conflicts. Recent news highlights a proposed $200 billion increase in U.S. defense spending, directly benefiting defense tech providers like AeroVironment.
- Solid Balance Sheet: The company maintains a strong current ratio of 3.52 and a low debt-to-equity ratio of 0.07, indicating excellent liquidity and minimal financial leverage. This provides a crucial buffer to navigate the current operational turmoil without immediate solvency risk.
- Analyst Maintained Buy Ratings: Despite the severe stock decline, several institutional firms, including BTIG, Canaccord, and Jefferies, have maintained 'Buy' or equivalent ratings as of March 2026. This suggests some professional conviction that the long-term growth narrative remains intact despite recent setbacks.
- Deeply Oversold Technicals: The stock is trading at just 37.8% of its 52-week range ($156 to $417.86) and is down 45.7% over six months, indicating deeply oversold conditions. This technical extreme could represent an inflection point if the company demonstrates any fundamental stabilization.
Bearish
- Severe Fundamental Deterioration: Q3 FY2026 results showed a catastrophic collapse in profitability, with a net loss of -$156.6M and gross margin plummeting to 17.1% from 37.7% a year ago. This was driven by a massive goodwill impairment charge and severe margin compression, signaling deep operational issues.
- Critical Contract Loss & Revenue Slowdown: The termination of a critical $1.7 billion U.S. Space Force contract creates massive revenue uncertainty. This is reflected in a sharp deceleration in revenue growth to just 1.4% YoY in Q3, a stark contrast to the company's prior growth narrative.
- Persistent Cash Burn: The company is burning cash, with operating cash flow at -$5.1M and trailing-twelve-month free cash flow deeply negative at -$195.3M. This financial sustainability concern is critical as the company cannot fund operations internally without a rapid turnaround.
- Extreme Valuation De-Rating & Volatility: The stock has undergone a massive de-rating, with its PS ratio collapsing from 33.27x to 5.17x. Combined with a high beta of 1.355, this indicates the market has severely discounted the growth story, and the stock will remain highly volatile and sensitive to further negative news.
AVAV Technical Analysis
The stock is in a pronounced and severe downtrend, having declined 45.7% over the past six months and 35.2% over the last three months, significantly underperforming the broader market. With a current price of $158, the stock is trading at just 37.8% of its 52-week range ($156 to $417.86), indicating it is near its yearly lows and in deeply oversold territory, which could represent either a value trap or a potential inflection point if fundamentals stabilize. Recent momentum remains decisively negative, with the stock down 20.4% over the past month, a continuation and acceleration of the longer-term downtrend, signaling persistent selling pressure and a lack of near-term catalysts to reverse sentiment. The stock's beta of 1.355 indicates it is 35.5% more volatile than the market, which has amplified its downside during this sell-off, a critical factor for risk management. Key technical support is firmly established at the 52-week low of $156, while resistance is far overhead at the 52-week high of $417.86; a sustained breakdown below $156 would signal a new phase of weakness, whereas any recovery would need to contend with significant overhead supply from investors trapped in the precipitous decline from the $400 level earlier this year.
Beta
1.35
1.35x market volatility
Max Drawdown
-61.5%
Largest decline past year
52-Week Range
$156-$418
Price range past year
Annual Return
+3.9%
Cumulative gain past year
| Period | AVAV Return | S&P 500 |
|---|---|---|
| 1m | -17.1% | +4.8% |
| 3m | -34.2% | +8.2% |
| 6m | -36.1% | +13.1% |
| 1y | +3.9% | +27.9% |
| ytd | -32.0% | +9.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AVAV Fundamental Analysis
Revenue growth has decelerated sharply and profitability has collapsed, with the most recent Q3 FY2026 revenue of $408.0 million representing only a 1.4% year-over-year increase, a stark slowdown from prior quarters. The company swung to a significant net loss of -$156.6 million in Q3, driven by a massive goodwill impairment charge, compared to a net loss of -$1.8 million in the year-ago quarter, indicating severe fundamental deterioration. Gross margin plummeted to 17.1% in Q3 from 37.7% a year ago, reflecting severe margin compression, while the operating margin turned negative at -5.1%, down from -1.8% in the prior year's Q3. The balance sheet shows a strong current ratio of 3.52 and a low debt-to-equity ratio of 0.07, indicating solid liquidity and low financial leverage. However, cash flow generation has turned deeply negative, with operating cash flow at -$5.1 million and free cash flow (TTM) at -$195.3 million, meaning the company is burning cash and cannot fund operations internally, raising concerns about its financial sustainability absent a rapid operational turnaround.
Quarterly Revenue
$408045000.0B
2026-01
Revenue YoY Growth
+1.43%
YoY Comparison
Gross Margin
+0.17%
Latest Quarter
Free Cash Flow
$-195302000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AVAV Overvalued?
Given the company's negative net income of -$156.6 million for the latest quarter, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is elevated at 5.17x, while the forward-looking metric is not directly available for comparison, though analyst revenue estimates for the coming year suggest the market is still assigning a premium multiple despite recent troubles. Compared to the Aerospace & Defense industry, specific average multiples are not provided in the data, but a PS ratio above 5x for a company with contracting margins and significant operational issues suggests it may not be trading at a deep discount. Historically, the stock's own valuation has compressed dramatically from much higher levels; for instance, its PS ratio was 33.27x as of Q3 FY2026, indicating the current 5.17x represents a massive de-rating. Trading near the bottom of its historical valuation range reflects the market's severe discount for the recent contract losses, impairment charges, and broken growth narrative, pricing in a scenario of fundamental deterioration rather than a temporary setback.
PE
97.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -820x~33224x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
40.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and immediate. The company swung to a -$156.6M net loss in Q3, driven by a massive goodwill impairment, indicating potential overpayment for past acquisitions. Gross margin collapsed by over 20 percentage points to 17.1%, revealing severe pricing pressure or cost inefficiencies. Most critically, the company is burning cash with -$195.3M in TTM free cash flow, raising questions about its ability to self-fund without tapping its balance sheet or capital markets. Revenue concentration risk is highlighted by the termination of a single $1.7B Space Force contract, which can cause significant earnings volatility.
Market & Competitive Risks are elevated. Despite the 45%+ price decline, the stock's PS ratio of 5.17x may still not represent a deep discount given the broken growth story and negative margins, leaving room for further valuation compression. The successful $320M IPO of drone maker AEVEX underscores intense competition and investor appetite for newer entrants in the unmanned systems space, potentially diverting capital and contracts. The stock's high beta of 1.355 means it is 35.5% more volatile than the market, amplifying downside during sector-wide sell-offs or if the broader defense rally fueled by geopolitical news falters.
Worst-Case Scenario involves a continuation of the current operational spiral. This chain would see further contract losses or delays, inability to restore margins, and sustained cash burn eroding the strong balance sheet. Investor confidence could completely evaporate, leading to a liquidity crisis or a dilutive capital raise. The realistic downside is significant; a break below the key $156 support (the 52-week low) could trigger a new leg down. From the current price of $158, a retest and break of this level implies an immediate -1.3% loss, with a potential fall to the $120-$130 range (a -20% to -24% decline) if the company fails to stabilize operations in the next earnings report.